Phase IIb trial of Mtb72F-AS02A vaccine shows 54% protection against active pulmonary tuberculosis Oct. 5, 2018
Tumor-specific peptide-conjugated siRNA targeting CDCA1 effectively treats prostate cancer in mice Oct. 4, 2018
VE-303 results in accelerated gut microbiota restoration after antibiotics in phase I study Oct. 4, 2018
Medivir reports phase I data from ongoing study of birinapant with Keytruda in advanced solid tumors Oct. 4, 2018
Que Oncology opens phase II trial of Q-122 to treat vasomotor symptoms in breast cancer patients Oct. 4, 2018
Jiangsu Alphamab initiates first-in-human trial of KN-026 for advanced breast and gastric cancer Oct. 4, 2018
RSS